AngioDynamics (ANGO) Competitors $9.32 -0.16 (-1.69%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$9.86 +0.54 (+5.78%) As of 07/11/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ANGO vs. TMO, WST, IART, OFIX, SRDX, ARAY, RMTI, RSLS, ABT, and ISRGShould you be buying AngioDynamics stock or one of its competitors? The main competitors of AngioDynamics include Thermo Fisher Scientific (TMO), West Pharmaceutical Services (WST), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), and Intuitive Surgical (ISRG). These companies are all part of the "medical" sector. AngioDynamics vs. Its Competitors Thermo Fisher Scientific West Pharmaceutical Services Integra LifeSciences Orthofix Medical Surmodics Accuray Rockwell Medical ReShape Lifesciences Abbott Laboratories Intuitive Surgical Thermo Fisher Scientific (NYSE:TMO) and AngioDynamics (NASDAQ:ANGO) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, dividends, valuation, earnings, profitability and analyst recommendations. Is TMO or ANGO more profitable? Thermo Fisher Scientific has a net margin of 15.19% compared to AngioDynamics' net margin of -14.61%. Thermo Fisher Scientific's return on equity of 17.15% beat AngioDynamics' return on equity.Company Net Margins Return on Equity Return on Assets Thermo Fisher Scientific15.19% 17.15% 8.47% AngioDynamics -14.61%-3.73%-2.43% Does the media favor TMO or ANGO? In the previous week, Thermo Fisher Scientific had 71 more articles in the media than AngioDynamics. MarketBeat recorded 74 mentions for Thermo Fisher Scientific and 3 mentions for AngioDynamics. Thermo Fisher Scientific's average media sentiment score of 1.14 beat AngioDynamics' score of 0.93 indicating that Thermo Fisher Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Thermo Fisher Scientific 48 Very Positive mention(s) 7 Positive mention(s) 9 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive AngioDynamics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, TMO or ANGO? Thermo Fisher Scientific has higher revenue and earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioThermo Fisher Scientific$42.88B3.83$6.34B$17.0525.51AngioDynamics$303.91M1.25-$184.35M-$1.01-9.23 Do analysts rate TMO or ANGO? Thermo Fisher Scientific currently has a consensus target price of $600.30, suggesting a potential upside of 37.99%. AngioDynamics has a consensus target price of $14.00, suggesting a potential upside of 50.21%. Given AngioDynamics' stronger consensus rating and higher probable upside, analysts plainly believe AngioDynamics is more favorable than Thermo Fisher Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Thermo Fisher Scientific 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80AngioDynamics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk and volatility, TMO or ANGO? Thermo Fisher Scientific has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500. Comparatively, AngioDynamics has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Do institutionals & insiders believe in TMO or ANGO? 89.2% of Thermo Fisher Scientific shares are held by institutional investors. Comparatively, 89.4% of AngioDynamics shares are held by institutional investors. 0.3% of Thermo Fisher Scientific shares are held by insiders. Comparatively, 5.4% of AngioDynamics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryThermo Fisher Scientific beats AngioDynamics on 12 of the 16 factors compared between the two stocks. Get AngioDynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ANGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANGO vs. The Competition Export to ExcelMetricAngioDynamicsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$384.95M$6.82B$5.61B$9.11BDividend YieldN/A1.25%5.24%4.02%P/E Ratio-9.2324.8927.9620.25Price / Sales1.2565.26430.8999.65Price / Cash2.2120.9237.4658.16Price / Book1.824.648.045.49Net Income-$184.35M$174.76M$3.18B$250.27M7 Day Performance-2.82%-1.00%3.67%4.80%1 Month Performance-14.42%-1.49%4.09%7.68%1 Year Performance55.33%4.27%29.58%16.36% AngioDynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANGOAngioDynamics3.951 of 5 stars$9.32-1.7%$14.00+50.2%+52.0%$384.95M$303.91M-9.23760News CoverageUpcoming EarningsTMOThermo Fisher Scientific4.9925 of 5 stars$418.76-2.5%$604.05+44.2%-19.8%$162.07B$42.88B24.56125,000Trending NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionWSTWest Pharmaceutical Services4.8049 of 5 stars$221.49-0.3%$320.00+44.5%-31.9%$15.97B$2.89B34.7710,600IARTIntegra LifeSciences4.1484 of 5 stars$12.75-5.5%$18.63+46.1%-58.9%$1.05B$1.61B-33.554,396OFIXOrthofix Medical2.9828 of 5 stars$10.72-3.6%$21.50+100.6%-28.8%$435.69M$799.49M-2.911,616SRDXSurmodics4.2944 of 5 stars$29.66-1.1%$43.00+45.0%-26.8%$428.83M$126.08M-21.34450ARAYAccuray2.7666 of 5 stars$1.34-5.6%N/A-31.0%$146.28M$446.55M0.001,040Positive NewsRMTIRockwell Medical4.1364 of 5 stars$0.80-3.1%$4.00+401.9%-46.3%$28.12M$101.49M0.00300Positive NewsRSLSReShape Lifesciences0.4888 of 5 stars$2.38+0.4%N/A-99.3%$5.65M$8.01M-0.0150ABTAbbott Laboratories4.9572 of 5 stars$133.62-0.6%$142.61+6.7%+26.7%$233.90B$42.34B17.33114,000Trending NewsUpcoming EarningsAnalyst ForecastISRGIntuitive Surgical4.6824 of 5 stars$534.71-1.8%$588.95+10.1%+15.5%$195.15B$8.35B78.4015,638Positive NewsAnalyst Forecast Related Companies and Tools Related Companies Thermo Fisher Scientific Competitors West Pharmaceutical Services Competitors Integra LifeSciences Competitors Orthofix Medical Competitors Surmodics Competitors Accuray Competitors Rockwell Medical Competitors ReShape Lifesciences Competitors Abbott Laboratories Competitors Intuitive Surgical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ANGO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AngioDynamics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AngioDynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
